Catalyst Pharmaceutical (CPRX) reported $148.39 million in revenue for the quarter ended September 2025, representing a year-over-year increase of 15.3$0.68 for the same period compares to $0.57 a year ago.The reported revenue represents a surprise of +8.77$136.43 million. With the consensus EPS estimate being $0.51, the EPS surprise was +33.33%.While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they co ...